New fields are being explored to bring novel antibody candidates to the pipeline.

Pushing the Barriers in Next-Gen Antibody Development

The development of CAR-T therapies for solid tumor cancers presents a myriad of challenges.

Challenges of Expanding CAR-T Cell Therapy into Solid Tumors

The COVID-19 vaccines opened the door to powerful market potential for other nucleic acid-based therapies.

Ramping Up Development of Nucleic Acid Therapies

Topic

Editor of Pharmaceutical Technology Europe

Articles

Biologics formulation comes with a unique set of challenges, which can be overcome through innovative strategies and good partnerships. 

Navigating Biologics Development

Webcasts

Webinar Date/Time: Tue, Oct 17, 2023 10:00 AM EDT


Process Intensification Strategies to Improve Protein A Resin Cost Effectiveness

Cheryl Barton is director of PharmaVision, 

Tumour-infiltrating lymphocyte (TIL) therapies offer a new route to target cancer.

Harnessing the Power of Oncolytic Viruses

Videos

Maik Jornitz, Principal Consultant, BioProcess Resources LLC, discusses the definition of patient safety and how to implement new technologies into upgraded facilities.

The Definition of Patient Safety and Implementing Technologies (PDA/FDA Joint Regulatory Conference 2023)

Feliza Mirasol is the science editor for 

The EMA’s Committee for Medicinal Products for Human Use has given a positive opinion on Sandoz’ biosimilar trastuzumab for breast and gastric cancer.

EMA Committee Issues Positive Opinion on Sandoz’ Biosimilar Trastuzumab

Andreas Dreps, PhD, is SVP, Drug Development Services at ICON

Martin Lachs, PhD, is VP, Project Management Oncology at ICON.

Despite its success, clinical and logistical roadblocks to mRNA cancer vaccine development remain.

Logistical Considerations in mRNA Vaccine Development

Recipharm will provide analytical and process development capabilities to support toxicology studies, in addition to GLP manufacturing of lipid nanoparticles to capture the active pharmaceutical ingredient, an antigen peptide. 

Recipharm Partners with Ahead Therapeutics to Develop Rare Autoimmune Disease Therapy 

The agreement states that Orbit will implement its bead-based peptide display engine to discover peptide leads specific to targets related to specific tumors.

Orano Med and Orbit Discovery Enter Collaboration for New Novel Targeted Radioligand Therapies 

Nanoparticles offer the potential for a safer, more effective method of drug delivery to the patient.

Nanoparticle Engineering in Drug Delivery Under the Microscope

Anurag S. Rathore is a professor in the Department of Chemical Engineering at the Indian Institute of Technology Delhi and a member of 

l's Editorial Advisory Board, Tel. +91.9650770650, asrathore@biotechcmz.com.

Shravan Sreenivasan is research scholars at the Department of Chemical Engineering, Indian Institute of Technology New Delhi.

Image analysis algorithms coupled with microscopy techniques can be used to characterize aggregates of therapeutic proteins.